Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Trials|August 7, 2019
Whole brain radiotherapy (WBRT) after local treatment of brain metastases in melanoma patients: Statistical Analysis PlanSerigne N Lo, Angela M Hong, Lauren E Haydu, et al.
Journal of the American Academy of Dermatology|July 19, 2025
Radiotherapy versus imiquimod for complex lentigo maligna: A phase 3 randomized clinical trialAngela M Hong, Serigne N Lo, Gerald B Fogarty, et al.
European Journal of Cancer (Oxford, England : 1990)|June 14, 2021
Re-defining the role of surgery in the management of patients with oligometastatic stage IV melanoma in the era of effective systemic therapiesSydney Ch'ng, Semra Uyulmaz, Matteo S Carlino, et al.
Australian Journal of General Practice|May 29, 2020
Australian general practitioners' attitudes and knowledge of sentinel lymph node biopsy in melanoma managementCaroline G Watts, Andrea L Smith, Sam Robinson, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Distinct Sarcoma Microenvironments Predict Benefit from Addition of Pembrolizumab to Preoperative Radiotherapy and Surgery in SU2C-SARC032Stefano Testa, Jonathon E Himes, Ajay Subramanian, et al.
BMJ Open|May 4, 2026
Pre-diagnostic route reported by patients with sarcoma from the Netherlands, the UK, Australia and New Zealand: early detection challenges for general practitioners - an international observational cohort studyEmily I Holthuis, Vicky L M N Soomers, Meena Rafiq, et al.
Journal of the American Academy of Dermatology|December 20, 2025
A cost comparison of radiotherapy and topical imiquimod for lentigo maligna treatment: considerations for clinical decision-makingPascale Guitera, Serigne N Lo, Jonathan Stretch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 26, 2019
Adjuvant Whole-Brain Radiation Therapy Compared With Observation After Local Treatment of Melanoma Brain Metastases: A Multicenter, Randomized Phase III TrialAngela M Hong, Gerald B Fogarty, Kari Dolven-Jacobsen, et al.
Pigment Cell & Melanoma Research|February 16, 2019
Incidence, features and management of radionecrosis in melanoma patients treated with cerebral radiotherapy and anti-PD-1 antibodiesInes Pires da Silva, Isabella C Glitza, Lauren E Haydu, et al.
Lancet (London, England)|November 15, 2024
Safety and efficacy of pembrolizumab, radiation therapy, and surgery versus radiation therapy and surgery for stage III soft tissue sarcoma of the extremity (SU2C-SARC032): an open-label, randomised clinical trialYvonne M Mowery, Karla V Ballman, Angela M Hong, et al.
Pageof 6